Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 1 Mar 2014

Villar H E, Jugo M B, Visser M, Hidalgo M, Hidalgo G, Maccallini G C

Abstract excerpt

INTRODUCTION: The occurrence of community-associated infections due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is increasing worldwide. These organisms are frequently resistant to many of the antimicrobial agents but remain susceptible to carbapenems. We investigated the i...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Lactamases
Share to beta-Lactams
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Escherichia coli Infections

Share to Imipenem

Share to Meropenem

Share to Microbial Sensitivity Tests

Share to Thienamycins

Source

Identifiers

PMID: 24676243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24676243-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].PMID 24676243Read ↗

Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.Semantic proximity Read ↗

Emergence of imipenem resistance in clinical Escherichia coli during therapy.Semantic proximity Read ↗

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013.Semantic proximity Read ↗

Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007.Semantic proximity Read ↗

Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli strain.Semantic proximity Read ↗

Susceptibility of <i>Klebsiella pneumoniae</i> Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant IsolatesSemantic proximity Read ↗

Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.Semantic proximity Read ↗

[Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].Semantic proximity Read ↗

Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital.Semantic proximity Read ↗

[Resistance to the latest beta-lactams: mechanisms of acquisition and spread of resistance in Enterobacteriaceae].Semantic proximity Read ↗

Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli.Semantic proximity Read ↗

An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.